“…All of these current NA inhibitors were designed based upon the structure of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Neu5Ac2en), a putative NA transition-state analogue 8,[10][11][12] . Insight into the NA catalytic mechanism and the proposed oxocarbenium ion transition-state intermediate were crucial for the design of Neu5Ac2en analogues with potent NA inhibitory activity 13,14 . However, evidence regarding the key influenza NA catalytic residues has remained elusive and the successful design of highly effective next-generation influenza NA inhibitors has proven to be a difficult task.…”